Prior to joining CSB’s Board of Directors in October 2022, Phoebus spent 18 years as a complex derivatives trader and 13 years as an asset manager, across all main asset classes. In the first part of his ‘sell-side’ career, he traded complex equity, interest-rate, foreign-exchange, credit and hybrid derivatives at Bankers Trust, Credit Suisse, Bear Stearns, and Gen Re Securities (1992-2001). In the second part, he traded and structured complex equity and strategic derivatives at CDC-IXIS, TD Securities, and ABN-AMRO/RBS (2002-2009). During this time, he served as global head variously of quantitative trading, structuring, execution and trading risk, set up or restructured client and proprietary desks globally, and supervised  and directed variously pricing, execution, positioning, risk management, and business risk mitigation.

During his ensuing ‘buy-side’ career, Phoebus was co-founder and CIO of a Swiss multi-family office (where he advised inter alia on investment banking exercises in offshore oil and gas, mining, shipping and telecoms) and a multiply-awarded Swiss fund management company (of whose enlarged successor entity he remains a manager), as well as director of a Cayman private-markets mutual fund (where he still serves). From mid-2015 through 2018, he was a MD at UBS Asset Management, where he advised the C-Suite on risk exposures and investment performance drivers, and participated by invitation in strategic (M&A), finance (RWA/LRD), accounting and regulatory projects at Group-CEO level.

Since 2019, Phoebus has served as director and counsel of a Dutch international financial services and financial technology group, and as legal advisor at a Swiss law firm. In February 2023, he was appointed as a director of Investors Europe (Mauritius) Ltd, an internationally-licensed cross-markets financial intermediary.

Phoebus holds a BA cum laude (Economics) from Harvard University, a MPhil (Finance) from University of Cambridge, and a MSc (Economics) from London School of Economics.